Meletios Dimopoulos, Ramon Garcia Sanz, Hui-Peng Lee, Marek Trneny, Marzia Varettoni Stephen Opat, Shirley D’Sa, Roger G. Owen, Gavin Cull, Stephen Mulligan, Jaroslaw Czyz, Jorge J. Castillo, Marina Motta, Tanya Siddiqi, Mercedes Gironella Mesa, Miquel Granell Gorrochategui, Dipti Talaulikar, Pier Luigi Zinzani, Elham Askari, Sebastian Grosicki, Albert Oriol, Simon Rule, Janusz Kloczko, Alessandra Tedeschi, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jan Michel, Jingjing Schneider, Ziwen Tan, Aileen Cohen, Jane Huang, and Constantine S. Tam, for the ASPEN investigators
Zanubrutinib for the treatment of MYD88 wild-type WM: a substudy of the phase 3 ASPEN trial
Submitted 21 July 2020; accepted 9 October 2020; published online 7 December 2020. DOI 10.1182/bloodadvances.2020003010